Company OUTLOOK THERAPEUTICS, INC. Nasdaq
Equities
US68235M1053
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
C. Trenary
CEO | Chief Executive Officer | 66 | 21-07-06 |
Lawrence Kenyon
DFI | Director of Finance/CFO | 58 | 15-09-14 |
Surendra Sharma
CTO | Chief Tech/Sci/R&D Officer | - | 23-01-18 |
Terry Dagnon
COO | Chief Operating Officer | 62 | 18-10-31 |
Alicia Tozier
SAM | Sales & Marketing | - | 22-03-01 |
Joel Prieve
PRN | Corporate Officer/Principal | - | 22-02-07 |
Jeff Evanson
PRN | Corporate Officer/Principal | 55 | 18-10-31 |
Jennifer Kissner
PRN | Corporate Officer/Principal | - | 19-04-25 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Randy Thurman
CHM | Chairman | 74 | 18-04-12 |
Kurt Hilzinger
BRD | Director/Board Member | 63 | 15-12-10 |
C. Trenary
CEO | Chief Executive Officer | 66 | 21-07-06 |
Lawrence Kenyon
DFI | Director of Finance/CFO | 58 | 15-09-14 |
Yazan Haddadin
BRD | Director/Board Member | 48 | 17-10-30 |
Julian Gangolli
BRD | Director/Board Member | 66 | 20-04-19 |
Gerd Auffarth
BRD | Director/Board Member | 59 | 20-04-19 |
Julia Haller
BRD | Director/Board Member | 69 | 22-08-10 |
Director/Board Member | 39 | 17-09-10 | |
Andong Huang
BRD | Director/Board Member | 27 | 20-06-18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 22,298,542 | 13,636,212 ( 61.15 %) | 0 | 61.15 % |
Company contact information
Outlook Therapeutics, Inc.
485 Route 1 South Building F, Suite 320
08852, Iselin
+609 619 3990
http://www.outlooktherapeutics.comSector
1st Jan change | Capi. | |
---|---|---|
-0.02% | 42.11B | |
+48.49% | 40.08B | |
+5.04% | 40B | |
-11.32% | 26.87B | |
+5.25% | 24.58B | |
-23.83% | 18.44B | |
-1.62% | 11.94B | |
+22.75% | 11.66B | |
+6.44% | 11.01B |